Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi Metallo-β-lactamase
- PMID: 21258100
- PMCID: PMC3106237
- DOI: 10.1093/cid/ciq178
Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi Metallo-β-lactamase
Abstract
Carbapenem resistance in Klebsiella pneumoniae is most notably due to the K. pneumoniae carbapenemase (KPC) β-lactamase. In this report, we describe the occurrence of a newly described mechanism of carbapenem resistance, the NDM-1 β-lactamase, in a patient who received medical attention (but was not hospitalized) in India.
Comment in
-
New Delhi metallo-β-lactamase and multidrug resistance: a global SOS?Clin Infect Dis. 2011 Feb 15;52(4):485-7. doi: 10.1093/cid/ciq179. Clin Infect Dis. 2011. PMID: 21258101 No abstract available.
References
-
- Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis. 2009;9:228–36. - PubMed
-
- Souli M, Galani I, Antoniadou A, et al. An outbreak of infection due to β-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes. Clin Infect Dis. 2010;50:364–73. - PubMed
-
- Bratu S, Landman D, Haag R, et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med. 2005;165:1430–5. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical